Gene · 2877
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adaptive evolution of antioxidase-related genes in hypoxia-tolerant mammals. | Front Genet | 2024 | 38725483 | PubTator, text mining | PubMed |
| The Crucial Value of Glutathione Peroxidase 2 to Understand the 'Two-Faced' Role of Reactive Oxygen Species in Lung Adenocarcinoma. | Ann Surg Oncol | 2024 | 38702392 | PubTator, text mining | PubMed |
| Exploration of individual colorectal cancer cell responses to H2O2 eustress using hopping probe scanning ion conductance microscopy. | Sci Bull (Beijing) | 2024 | 38644130 | PubTator, text mining | PubMed |
| Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma. | Cancer Biomark | 2024 | 38517778 | PubTator, text mining | PubMed |
| Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapse. | Cell Rep Med | 2024 | 38508142 | PubTator, text mining | PubMed |
| ASO Author Reflections: Impact of Glutathione Peroxidase 2 (GPX2) in Lung Adenocarcinoma. | Ann Surg Oncol | 2024 | 38494560 | PubTator, text mining | PubMed |
| Clinical and Prognostic Significance of Glutathione Peroxidase 2 in Lung Adenocarcinoma. | Ann Surg Oncol | 2024 | 38461192 | PubTator, text mining | PubMed |
| CYLD induces high oxidative stress and DNA damage through class I HDACs to promote radiosensitivity in nasopharyngeal carcinoma. | Cell Death Dis | 2024 | 38287022 | PubTator, text mining | PubMed |
| The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. | J Cancer Res Clin Oncol | 2024 | 38279987 | PubTator, text mining | PubMed |
| BRMS1L confers anticancer activity in non-small cell lung cancer by transcriptionally inducing a redox imbalance in the GPX2-ROS pathway. | Transl Oncol | 2024 | 38262108 | PubTator, text mining | PubMed |
| The Tumor Suppressor SOCS1 Diminishes Tolerance to Oxidative Stress in Hepatocellular Carcinoma. | Cancers (Basel) | 2024 | 38254783 | PubTator, text mining | PubMed |
| Adipose Stromal Cell-Derived Secretome Attenuates Cisplatin-Induced Injury In Vitro Surpassing the Intricate Interplay between Proximal Tubular Epithelial Cells and Macrophages. | Cells | 2024 | 38247813 | PubTator, text mining | PubMed |
| Macro CD5L+ deteriorates CD8+T cells exhaustion and impairs combination of Gemcitabine-Oxaliplatin-Lenvatinib-anti-PD1 therapy in intrahepatic cholangiocarcinoma. | Nat Commun | 2024 | 38245530 | PubTator, text mining | PubMed |
| Redox signalling regulates breast cancer metastasis via phenotypic and metabolic reprogramming due to p63 activation by HIF1α. | Br J Cancer | 2024 | 38238426 | PubTator, text mining | PubMed |
| Astringency sensitivity to tannic acid: Effect of ageing and salivary proline-rich protein levels. | Food Chem (Oxf) | 2024 | 38234464 | PubTator, text mining | PubMed |
| Genetic Determinants of Selenium Availability, Selenium-Response, and Risk of Polycystic Ovary Syndrome. | Biol Trace Elem Res | 2024 | 38227265 | PubTator, text mining | PubMed |
| Interaction of human keratinocytes and nerve fiber terminals at the neuro-cutaneous unit. | Elife | 2024 | 38225894 | PubTator, text mining | PubMed |
| Formononetin ameliorates cisplatin-induced hair cell death via activation of the PI3K/AKT-Nrf2 signaling pathway. | Heliyon | 2024 | 38192850 | PubTator, text mining | PubMed |
| Electronic cigarette vapor disrupts key metabolic pathways in human lung epithelial cells. | Saudi Pharm J | 2024 | 38090735 | PubTator, text mining | PubMed |
| Zerumbone liquid crystalline nanoparticles protect against oxidative stress, inflammation and senescence induced by cigarette smoke extract in vitro. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 37851060 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2877/papers?page=5